Hollenberg PF[au] - Search Results

Year	Number of Results
1965	1
1969	1
1971	1
1972	1
1973	2
1974	1
1975	1
1977	1
1980	7
1981	1
1982	1
1983	6
1984	4
1985	5
1986	2
1987	4
1988	1
1989	4
1991	1
1992	1
1993	2
1994	5
1995	4
1996	7
1997	6
1998	7
1999	9
2000	8
2001	7
2002	8
2003	9
2004	13
2005	11
2006	8
2007	9
2008	5
2009	8
2010	12
2011	8
2012	9
2013	8
2014	1
2015	3
2016	6
2017	2
2018	3
2021	0

1

Enzymology in Chemical Toxicology: Beyond P450s.

Hollenberg PF. Hollenberg PF. Chem Res Toxicol. 2016 Sep 19;29(9):1365-6. doi: 10.1021/acs.chemrestox.6b00263. Chem Res Toxicol. 2016. PMID: 27640214 No abstract available.

2

Chemical toxicology in China: a special issue.

Zhu BZ, Hollenberg PF. Zhu BZ, et al. Among authors: hollenberg pf. Chem Res Toxicol. 2015 Mar 16;28(3):279-80. doi: 10.1021/acs.chemrestox.5b00062. Chem Res Toxicol. 2015. PMID: 25772477 No abstract available.

3

Assay of Endocannabinoid Oxidation by Cytochrome P450.

Snider NT, Walker VJ, Hollenberg PF. Snider NT, et al. Among authors: hollenberg pf. Methods Mol Biol. 2016;1412:227-36. doi: 10.1007/978-1-4939-3539-0_23. Methods Mol Biol. 2016. PMID: 27245908

4

Oxidation of the endogenous cannabinoid arachidonoyl ethanolamide by the cytochrome P450 monooxygenases: physiological and pharmacological implications.

Snider NT, Walker VJ, Hollenberg PF. Snider NT, et al. Among authors: hollenberg pf. Pharmacol Rev. 2010 Mar;62(1):136-54. doi: 10.1124/pr.109.001081. Epub 2010 Feb 4. Pharmacol Rev. 2010. PMID: 20133390 Free PMC article. Review.

5

Mechanism-based inactivation of human cytochromes p450s: experimental characterization, reactive intermediates, and clinical implications.

Hollenberg PF, Kent UM, Bumpus NN. Hollenberg PF, et al. Chem Res Toxicol. 2008 Jan;21(1):189-205. doi: 10.1021/tx7002504. Epub 2007 Dec 4. Chem Res Toxicol. 2008. PMID: 18052110 Review.

6

Mechanisms of cytochrome P450 and peroxidase-catalyzed xenobiotic metabolism.

Hollenberg PF. Hollenberg PF. FASEB J. 1992 Jan 6;6(2):686-94. doi: 10.1096/fasebj.6.2.1537457. FASEB J. 1992. PMID: 1537457 Review.

7

Targeting of the highly conserved threonine 302 residue of cytochromes P450 2B family during mechanism-based inactivation by aryl acetylenes.

Zhang H, Lin HL, Kenaan C, Hollenberg PF. Zhang H, et al. Among authors: hollenberg pf. Arch Biochem Biophys. 2011 Mar 1;507(1):135-43. doi: 10.1016/j.abb.2010.09.006. Epub 2010 Sep 15. Arch Biochem Biophys. 2011. PMID: 20836985 Free PMC article. Review.

8

Characteristics and common properties of inhibitors, inducers, and activators of CYP enzymes.

Hollenberg PF. Hollenberg PF. Drug Metab Rev. 2002 Feb-May;34(1-2):17-35. doi: 10.1081/dmr-120001387. Drug Metab Rev. 2002. PMID: 11996009 Review. No abstract available.

9

Oxidative hemoglobin reactions: Applications to drug metabolism.

Spolitak T, Hollenberg PF, Ballou DP. Spolitak T, et al. Among authors: hollenberg pf. Arch Biochem Biophys. 2016 Jun 15;600:33-46. doi: 10.1016/j.abb.2016.04.007. Epub 2016 Apr 16. Arch Biochem Biophys. 2016. PMID: 27091316

10

Mechanism-based inactivators as probes of cytochrome P450 structure and function.

Kent UM, Juschyshyn MI, Hollenberg PF. Kent UM, et al. Among authors: hollenberg pf. Curr Drug Metab. 2001 Sep;2(3):215-43. doi: 10.2174/1389200013338478. Curr Drug Metab. 2001. PMID: 11513328 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results